glp-1 weight loss drug news today New alternative, eloralintide, leads to 20% in trial Study: GLP-1 Weight Loss Drugs

Short-acting drugs primarily lower postprandial blood glucose levels by slowing gastric emptying, while long-acting GLP-1 RAs are more effective at reducing fasting blood glucose levels, mainly by promoting insulin secretion and inhibiting glucagon release

While waiting for additional research, the big question for oncologists is: what to do now

10.1016/j.physbeh.2012.02.017 Physiol

GLP-1 drugs have ushered in a new era in weight loss

Optimize sleep hygiene and physical activity

* While weight loss can be challenging, working with a healthcare provider or diabetes educator to develop a plan can help you reach your body weight goals